- Sections
- A - Nécessités courantes de la vie
- A61K - Préparations à usage médical, dentaire ou pour la toilette
- A61K 38/15 - DepsipeptidesLeurs dérivés
Détention brevets de la classe A61K 38/15
Brevets de cette classe: 347
Historique des publications depuis 10 ans
|
28
|
32
|
37
|
35
|
33
|
25
|
21
|
27
|
29
|
8
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Pharma Mar, S.A. | 214 |
26 |
| Celgene Corporation | 1412 |
17 |
| Onkure, Inc. | 31 |
9 |
| Boehringer Ingelheim Animal Health USA Inc. | 417 |
9 |
| St. Jude Children's Research Hospital | 235 |
8 |
| Bayer Animal Health GmbH | 172 |
7 |
| University of Florida Research Foundation, Inc. | 4184 |
7 |
| NovoBiotic Pharmaceuticals, LLC | 23 |
7 |
| Zoetis Services LLC | 1542 |
7 |
| The Trustees of Columbia University in the City of New York | 3644 |
6 |
| Trustees of Boston University | 993 |
6 |
| Viracta Subsidiary, Inc | 17 |
6 |
| Animol Discovery, Inc. | 19 |
6 |
| Celgene Quanticel Research, Inc. | 154 |
5 |
| Fleurir ABX LLC | 12 |
5 |
| Elanco Animal Health GmbH | 351 |
5 |
| Chung-Ang University Industry-Academy Cooperation Foundation | 490 |
4 |
| Desert King International, LLC | 39 |
4 |
| Reapplix ApS | 19 |
4 |
| The Regents of the University of Colorado, a body corporate | 2818 |
4 |
| Autres propriétaires | 195 |